Quality assurance for in vitro alternative test methods:: Quality control issues in test kit production

被引:5
|
作者
Rispin, A
Harbell, JW
Klausner, M
Jordan, FT
Coecke, S
Gupta, K
Stitzel, K
机构
[1] US EPA, Off Pesticide Programs, Washington, DC 20460 USA
[2] Inst Vitro Sci Inc, Gaithersburg, MD USA
[3] MatTek Corp, Ashland, MA USA
[4] Charles River Endosafe Corp, Wilmington, MA USA
[5] European Ctr Validat Alternat Methods, Inst Hlth & Consumer Protect, European Commiss Joint Res Ctr, Ispra, Italy
[6] US Consumer Prod Safety Commiss, Bethesda, MD USA
[7] Consultant, W Chester, OH USA
关键词
alternative test methods; animal test replacement; GLP; good cell culture practice; Limulus assay; pyrogen testing; quality assurance; skin constructs; test kits;
D O I
10.1177/026119290403201s120
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In vitro toxicology methods are being adopted by regulatory agencies worldwide. Many of these methods have been validated by using proprietary materials, often in the form of test kits. Guidelines for the use of Good Laboratory Practice methods for in vitro methods have been proposed. However, users of the data from these methods also need to be reassured that the proprietary materials and the test kits will provide consistent, good quality data over time, not just during the validation process. This paper presents an overview of the methods currently used by representatives of kit manufacturers and contract testing laboratories to ensure that the results from methods that utilise test kits are reproducible over time and across different types of test materials. This information will be valuable as a basis for future discussion on the need for formalised oversight of the quality of these materials.
引用
收藏
页码:725 / 729
页数:5
相关论文
共 50 条